I-CHENGDU, I-CHINA / ACCESSWIRE / Agasti 20, 2021 / "Umbhiyozo we-26 we-Deebio we-26th yoMbhiyozo wokuThunyelelwa eJapan" wabanjwa ngempumelelo e-Chengdu, e-China, ngo-Matshi 29. Unjingalwazi u-Yu Rong, uMlawuli weSebe le-Biotechnology kunye ne-Pharmacology ye-West China School we-Pharmacy, iYunivesithi yaseSichuan, uGqr. Tang Can, uNjingalwazi oDityanisiweyo weSikole seSayensi yeBhayoloji kunye neTekhnoloji yeKholeji yezoNyango yaseChengdu, kunye noMnu Tan Ting, uMphathi Jikelele weBeijing Minkang Pharmaceutical Technology Co., Ltd., wayekho kulo mbhiyozo.
Ukusukela ekusekweni kwayo ngo-1994, iSichuan Deebio Pharmaceutical Co., Ltd. (emva koku ebizwa ngokuba yi-Deebio) igxile kwimakethi ye-bio-enzyme ekrwada.I-Deebio iye yaphuhla yaba yinkokeli yoshishino lwehlabathi ukusuka kumzi-mveliso omncinci wengingqi.Ngenzuzo yemveliso yendalo yebhayo-enzyme enkqenkqeza phambili kwihlabathi kunye nobuchule be-R&D, iimveliso zayo zithengiswa kumazwe angaphezu kwama-30 kwihlabathi liphela, ngesona sabelo sikhulu semarike yehlabathi kwiindidi zayo ezininzi zeemveliso.Ngeminyaka emininzi yomsebenzi onzima kodwa ukwazisa okuncinci, u-Deebio uye waba "yintshatsheli efihliweyo" ephantsi kunye nepragmatic kwishishini.
ISIBHENGEZO
Ukugcina uMgangatho oPhezulu kunye nokuKhokela iMarike yeHlabathi
"Umgangatho bubomi bukaDeebio," watsho uZhang Ge, uSihlalo weBhodi kunye noMongameli weDeebio, kudliwano-ndlebe.
Iimveliso ze-Deebio ze-bio-enzyme API zifikelele kweyona migangatho iphezulu yehlabathi.Iimveliso zinomsebenzi ophezulu, ukucoceka okuphezulu, kunye nozinzo oluphezulu, ukuhlangabezana neenkcukacha ezahlukeneyo zeemveliso zamaqabane.Iimveliso ezikumgangatho ophezulu azifumananga kuphela isatifikethi se-GMP e-China kunye ne-EU-GMP eYurophu, kodwa ziphinde zaphumelela uphicotho lwe-Sanofi, i-Celltrion, kunye ne-Nichi-Iko.
Imizamo engapheliyo yomgangatho ophezulu izise iDeebio imarike ebanzi.Kwiintsuku zokuqala zokusekwa kwayo, i-Deebio yaba ngumthengisi wehlabathi kuphela we-kallidinogenase ekrwada kumaqabane aseJapan anomgangatho ozinzileyo, inkonzo enomdla kunye nodumo oluhle.Okwangoku, i-kallidinogenase ngokusisiseko ihlala kwimarike yelizwe.I-Deebio ibe ngoyena mthengisi mkhulu we-pancreatin kwihlabathi;izabelo zentengiso ye-pepsin, i-trypsin-chymotrypsin kunye nezinye iimveliso zidlula i-30%;I-Deebio ikwanguye kuphela umthengisi we-elastase, isisombululo esicacileyo se-pepsin kunye ne-High Lipase Pancreatin APIs kwimarike yehlabathi.Iinkampani zamachiza ezidumileyo kwihlabathi njengeSanofi, Celltrion kunye noNichi-Iko baye baseka ubudlelwane bexesha elide kunye nozinzile kunye noDeebio.
“Siyayibulela impumelelo yenkampani yakho kumgangatho kunye nokuqonda okunzulu kwintengiso yemveliso.Ungumthengisi obalaseleyo we-API. "Iqabane laseJapan lika-Deebio i-Tohri & Company Ltd nayo ivakalise ukuqaphela kwayo i-Deebio kwileta yayo yokuvuyisana nayo.
Utyalo-mali oluqhubekayo ukuze kuphunyezwe uPhuhliso olukumgangatho oPhezulu
ISIBHENGEZO
Ngokutsho kukaZhang Ge, umgangatho wemveliso uya kuba yinto ephambili ephambili ukuze ufumane indawo kwi-world bio-enzyme API field.Ukuqinisekisa umgangatho ophezulu weemveliso, akwanele ukuthembela ngokunyanisekileyo kwiimali okanye kwintshiseko.Kuyimfuneko ukuba rhoqo utyale imali kwiteknoloji, ulawulo kunye neziseko zophuhliso.Yiloo nto kanye eyenziwa nguDeebio.
Okokuqala, utyalo-mali lwetekhnoloji.Ukuze kuphuculwe inqanaba lolawulo lobugcisa, kwi-2003, i-Deebio yaseka intsebenziswano ebizwa ngokuba yi-Deyang Sinozyme Pharmaceutical Co., Ltd. ngokubambisana neqabane laseJamani elinobuchwepheshe obungcono kunye nobuchule bokulawula.Ngethuba leminyaka ye-18 yentsebenziswano, iqabane laseJamani liye latyelela rhoqo i-Deebio ukunika isikhokelo kunye nokulawula, ukwazisa iindlela zokulawula umgangatho ophezulu we-Deebio, ukwenzela ukuphakamisa amandla olawulo lwenkqubo ye-Deebio kwinqanaba eliphezulu lamazwe ngamazwe.
Ukongezelela, u-Deebio uyaqhubeka nokutyalomali kuphando lwezobuchwepheshe.Kwi-1997, xa i-Deebio yakwazi ukugcina ukusebenza kwayo okuqhelekileyo, yaqala ukuphuhlisa intsebenziswano esondeleyo yophando-iyunivesithi-uphando kunye neeyunivesithi kunye namaziko ophando, kuquka iYunivesithi yaseTsinghua, i-Academy yaseTshayina yeSayensi, iYunivesithi yaseSichuan, iYunivesithi yaseChina yezoPharmaceutical, njl.
Ngeminyaka yamava obugcisa, i-Deebio idale inkqubo epheleleyo yokukhuselwa komsebenzi we-enzyme, ukusetyenziswa okungonakalisi kunye nobuchwepheshe obuchanekileyo bokucoca, ukuvelisa umsebenzi ophezulu, ukucoceka okuphezulu kunye nozinzo oluphezulu lwe-bio-enzymes.Ukongeza, u-Deebio unobuchule kakhulu kwaye unamava kwitekhnoloji yenkqubo yokucoca ibhayoloji kwaye ke ngoko uyakwazi ukuphuhlisa ngokukhawuleza iimveliso ezintsha kunye nokuphumeza imveliso yobuninzi.
Okwesibini, utyalo-mali lolawulo.Imveliso ye-Deebio kunye nolawulo lomgangatho lulandela ngokungqongqo inkqubo yolawulo ye-GMP yaseYurophu.Ikwanayo nomgangatho wolawulo lwenkqubo ye-US FDA, Japan PMDA, kunye ne-South Korea MFDS.
Okwesithathu, utyalo-mali lwemveliso yehardware.Kwi-2003, xa kwakunokwenzeka ukwakha i-factory ene-5 yezigidi ze-yuan, u-Deebio watyala imali ephindwe ka-4 loo mali ukwakha i-Sinozyme factory.Ngo-2012, yatyala imali kwakhona kulwakhiwo lwefektri yamayeza i-Deebio.Namhlanje, i-Deebio ineeworkshops ze-GMP ezi-4 ezinezixhobo eziphambili, ezifana nenkqubo evaliweyo eqhubekayo yokwahlula kunye nenkqubo ye-chromatography ezenzekelayo ezenzekelayo.Ikwatyale imali kulwakhiwo lweziko lokucocwa kwamanzi amdaka “lohlobo lwegadi” elinomthamo wokucocwa yonke imihla oyi-1,000m³, elithe laphumelela uphicotho lwe-EHS lweenkampani ezaziwayo kumazwe ngamazwe.I-Deebio ngoku ibe yenye yabakhiqizi abakhulu be-API be-bio-enzyme e-China.
Ukuqokelelwa okuqhubekayo kumashumi eminyaka kudale umqobo wokhuphiswano we-Deebio ongenako ukugqithwa ngoontanga bayo.
Uphuculo oluthe gqolo ukuPhakamisa uPhuhliso loShishino
Ukufunda rhoqo sisitshixo kubunkokeli beshishini bexesha elide likaDeebio.I-Deebio ayiqhubeki nje nokuhlaziya kunye nokwakha iifektri kodwa iqalisa ukuphucula ulawulo lwequmrhu kunye nokomeleza ukwakhiwa kwe-echelon yetalente.Iworkshop ye-GMP kaDeebio, eyakhiwe ngokuhambelana nemigangatho ye-FDA, yafakwa ngokusemthethweni kwimveliso ngoJuni.Ngoncedo lweNkampani yeSunsoar Strategy Consulting, isicwangciso seshishini sikaDeebio siye saphuculwa.Kwiminyaka yakutshanje, u-Deebio uye wenza iinzame ezinkulu zokwakha iqela elingcono kuzo zonke iinkalo ukusuka kwinkqubo yoqeqesho kunye nenkqubo yovavanyo ukuya kwinkqubo yetalente.
U-Deebio wenze inkqubela entsha kwiziqinisekiso kunye neemarike.NgokukaZhang Ge, u-Deebio ufaka isicelo sesatifikethi se-US FDA kunye nesatifikethi se-PMDA saseJapan.Kulo nyaka, baya kuqhubeka nokuphuhlisa imakethi yaseJapan kunye neTohri & Company Ltd yaseJapan.
“Ingqwalasela elinganayo kaDeebio kuhlaziyo nophuhliso lwemizimveliso iyachukumisa.Kwaye kube negalelo kuphuhliso lwelizwe lethu lamachiza ezinto eziphilayo kunye namalungiselelo ee-enzyme,” utshilo uYu Rong, uMlawuli weSebe leBiotechnology kunye nePharmacology yeSikole sase-West China seKhemesti, kwiYunivesithi yaseSichuan.
UDeebio ufana nesifundiswa esizinikele kuphando lwakhe.Uneprofayili ephantsi, i-pragmatic kwaye akazicingeli.Uphumelele imakethi yehlabathi ngamandla akhe kwaye wazuza ukunconywa kunye nentlonipho ngaphakathi nangaphandle kweshishini.
Ukuphenjelelwa ngubhubhane wehlabathi, ikamva laseTshayina lokuthumela ngaphandle kwe-API liyathembisa.Kwaye ngenxa yohlaziyo oluqhubekayo "lwecala lokubonelela" olukhuthazwa kukukhuselwa kwendalo, ukuvavanya ukuhambelana kunye nemigaqo-nkqubo yokuhlaziywa okuhambelanayo, ii-APIs zinokungena kwixesha elitsha lophuhliso.Kwimishini "engcono ye-Enzyme yoBomi obungcono", u-Deebio uye wavumela ihlabathi ukuba libone amandla okwenziwa kwe-bio-enzyme yase-China nokusebenza kwayo okubalaseleyo.Kwixesha elizayo, i-Deebio iya kubamba amathuba amaxesha kwaye ikhokelele ishishini kwinqanaba elitsha.
Uqhagamshelwano lwemidiya:
Umntu woQhagamshelwano: Selina Liu
I-imeyile:selina@deebio.com
Iwebhusayithi:http://www.deebiotech.com/
UMTHOMBO: Sichuan Deebiotech Corp., Ltd.
Jonga inguqulelo yomthombo kwi-accesswire.com:
Ixesha lokuposa: Aug-20-2021
